Sensei Biotherapeutics (SNSE) Institutional Ownership → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free SNSE Stock Alerts $1.01 +0.01 (+1.23%) (As of 12:18 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Institutional Ownership Changes (13F Filings) for Sensei Biotherapeutics (NASDAQ:SNSE)CurrentInstitutional OwnershipPercentage10.50%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$21.79K Get SNSE Insider Trade Alerts Want to know when executives and insiders are buying or selling Sensei Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SNSE Institutional Buying and Selling by Quarter Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. Sensei Biotherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/14/2023Newtyn Management LLC1,800,000$1.35M0.3%-1.5%7.200% 11/14/2022RA Capital Management L.P.683,529$1.06M0.0%-5.5%2.225% 7/22/2022Truist Financial Corp19,934$45K0.0%-60.5%0.065% 5/3/2022Leo Brokerage LLC14,845$34K0.0%N/A0.048% 11/16/2021Millennium Management LLC258,659$2.72M0.0%N/A0.846% 11/16/2021Moore Capital Management LP49,341$519K0.0%-61.3%0.161% Get the Latest News and Ratings for SNSE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sensei Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/12/2021Tao Capital Management LP32,784$345K0.1%N/A0.107% 11/12/2021The Manufacturers Life Insurance Company13,478$142K0.0%N/A0.044% 11/12/2021Geode Capital Management LLC273,978$2.88M0.0%+93.2%0.896% 11/10/2021Citigroup Inc.2,409$25K0.0%+565.5%0.008% 11/9/2021BlackRock Inc.1,000,322$10.52M0.0%+175.2%3.270% 11/5/2021Truist Financial Corp70,374$740K0.0%N/A0.230% 11/4/2021Deutsche Bank AG12,021$126K0.0%+158.3%0.039% 11/1/2021SG Americas Securities LLC12,614$133K0.0%N/A0.041% 10/13/2021BFT Financial Group LLC14,845$156K0.0%N/A0.049% 8/17/2021Citadel Advisors LLC283,667$2.77M0.0%-59.0%0.927% 8/16/2021Alyeska Investment Group L.P.40,000$390K0.0%N/A0.131% 8/16/2021Tudor Investment Corp Et Al28,111$274K0.0%-75.2%0.092% 8/16/2021Charles Schwab Investment Management Inc.54,965$537K0.0%+18.9%0.180% 8/16/2021State Street Corp100,000$976K0.0%+70.2%0.327% 8/13/2021Formula Growth Ltd.100,000$976K0.1%+77.7%0.327% 8/13/2021Northern Trust Corp75,011$733K0.0%-8.5%0.245% 8/13/2021Geode Capital Management LLC141,809$1.38M0.0%+20.8%0.464% 8/13/2021Vanguard Group Inc.387,753$3.78M0.0%+19.4%1.268% 8/12/2021JPMorgan Chase & Co.179,078$1.75M0.0%+15.1%0.585% 8/11/2021Bank of New York Mellon Corp18,431$180K0.0%+31.1%0.060% 8/11/2021BlackRock Inc.363,466$3.55M0.0%+9.2%1.188% 8/11/2021Deutsche Bank AG4,653$45K0.0%-73.3%0.015% 8/2/2021New York State Common Retirement Fund5,396$53K0.0%+37.2%0.018% 5/27/2021Davidson Kempner Capital Management LP26,000$376K0.0%N/A0.085% 5/21/2021Citadel Advisors LLC692,537$10.06M0.0%N/A2.264% 5/18/2021Zimmer Partners LP46,000$668K0.0%N/A0.150% 5/18/2021Tudor Investment Corp Et Al113,353$1.65M0.0%N/A0.371% 5/18/2021Duquesne Family Office LLC100,000$1.45M0.0%N/A0.327% 5/18/2021Davidson Kempner Capital Management LP26,000$376K0.0%N/A0.085% 5/18/2021Citadel Advisors LLC692,537$10.06M0.0%N/A2.264% 5/18/2021Falcon Edge Capital LP213,658$3.10M0.2%N/A0.699% 5/18/2021California State Teachers Retirement System11,494$167K0.0%N/A0.038% 5/17/2021Deerfield Management Company L.P. Series C375,000$5.45M0.1%N/A1.226% 5/17/2021Nuveen Asset Management LLC12,340$179K0.0%N/A0.040% top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution…5/13/2021Bank of New York Mellon Corp14,062$205K0.0%N/A0.046% 5/12/2021Serengeti Asset Management LP20,000$291K0.1%N/A0.065% 5/12/2021Northern Trust Corp81,947$1.19M0.0%N/A0.268% 5/12/2021Geode Capital Management LLC117,406$1.71M0.0%N/A0.384% 5/12/2021Pura Vida Investments LLC67,357$941K0.0%N/A0.220% 5/12/2021JPMorgan Chase & Co.155,647$2.26M0.0%N/A0.509% 5/12/2021UBS Group AG2,099$31K0.0%N/A0.007% 5/11/2021New York State Common Retirement Fund3,934$57K0.0%N/A0.013% 5/7/2021BlackRock Inc.332,700$4.83M0.0%N/A1.088% 5/7/2021American International Group Inc.4,441$65K0.0%N/A0.015% (Data available from 1/1/2016 forward) SNSE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SNSE shares? During the previous two years, the following institutional investors and hedge funds held shares of Sensei Biotherapeutics shares: Newtyn Management LLC ($1.35M), RA Capital Management L.P. ($1.06M), and Truist Financial Corp ($45K), Leo Brokerage LLC ($34K).Learn more on SNSE's institutional investors. What percentage of Sensei Biotherapeutics stock is owned by institutional investors? 10.50% of Sensei Biotherapeutics stock is owned by institutional investors. Learn more on SNSE's institutional investor holdings. Which institutional investors have been buying Sensei Biotherapeutics stock? The following institutional investors have purchased Sensei Biotherapeutics stock in the last 24 months: Leo Brokerage LLC ($14.85K). How much institutional buying is happening at Sensei Biotherapeutics? Institutional investors have bought a total of 14,845 shares in the last 24 months. This purchase volume represents approximately $34.29K in transactions. Which Sensei Biotherapeutics major shareholders have been selling company stock? The following institutional investors have sold Sensei Biotherapeutics stock in the last 24 months: RA Capital Management L.P. ($40.02K), Truist Financial Corp ($30.51K), and Newtyn Management LLC ($27.24K). How much institutional selling is happening at Sensei Biotherapeutics? Institutional investors have sold a total of 97,767 shares in the last 24 months. This volume of shares sold represents approximately $153.07K in transactions. Related Companies: XGN Major Shareholders DRRX Major Shareholders UBX Major Shareholders ADXN Major Shareholders LSTA Major Shareholders ITRM Major Shareholders ACXP Major Shareholders ALRN Major Shareholders ONCT Major Shareholders EYEN Major Shareholders This page (NASDAQ:SNSE) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensei Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
